Inhibikase Therapeutics, Inc. (IKT) Press Releases https://www.inhibikase.com/news/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo https://www.inhibikase.com Equisolve Investor Relations Suite <![CDATA[Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants]]> https://www.inhibikase.com/news/press-releases/detail/137/inhibikase-therapeutics-announces-pricing-of-100-million Thu, 20 Nov 25 21:54:00 -0500 https://www.inhibikase.com/news/press-releases/detail/137/inhibikase-therapeutics-announces-pricing-of-100-million <![CDATA[Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants]]> https://www.inhibikase.com/news/press-releases/detail/136/inhibikase-therapeutics-announces-proposed-public-offering Thu, 20 Nov 25 16:12:00 -0500 https://www.inhibikase.com/news/press-releases/detail/136/inhibikase-therapeutics-announces-proposed-public-offering <![CDATA[Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension]]> https://www.inhibikase.com/news/press-releases/detail/135/inhibikase-therapeutics-advancing-ikt-001-to-global-phase-3 Thu, 20 Nov 25 16:01:00 -0500 https://www.inhibikase.com/news/press-releases/detail/135/inhibikase-therapeutics-advancing-ikt-001-to-global-phase-3 <![CDATA[Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity]]> https://www.inhibikase.com/news/press-releases/detail/134/inhibikase-therapeutics-announces-third-quarter-2025 Fri, 14 Nov 25 16:01:00 -0500 https://www.inhibikase.com/news/press-releases/detail/134/inhibikase-therapeutics-announces-third-quarter-2025 <![CDATA[Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer]]> https://www.inhibikase.com/news/press-releases/detail/133/inhibikase-therapeutics-strengthens-leadership-team-with Tue, 19 Aug 25 08:00:00 -0400 https://www.inhibikase.com/news/press-releases/detail/133/inhibikase-therapeutics-strengthens-leadership-team-with <![CDATA[Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity]]> https://www.inhibikase.com/news/press-releases/detail/132/inhibikase-therapeutics-announces-second-quarter2025 Thu, 14 Aug 25 16:50:00 -0400 https://www.inhibikase.com/news/press-releases/detail/132/inhibikase-therapeutics-announces-second-quarter2025 <![CDATA[Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity]]> https://www.inhibikase.com/news/press-releases/detail/131/inhibikase-therapeutics-announces-first-quarter2025 Wed, 14 May 25 16:05:00 -0400 https://www.inhibikase.com/news/press-releases/detail/131/inhibikase-therapeutics-announces-first-quarter2025 <![CDATA[Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer]]> https://www.inhibikase.com/news/press-releases/detail/130/inhibikase-therapeutics-announces-appointment-of-david Mon, 14 Apr 25 08:00:00 -0400 https://www.inhibikase.com/news/press-releases/detail/130/inhibikase-therapeutics-announces-appointment-of-david <![CDATA[Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity]]> https://www.inhibikase.com/news/press-releases/detail/129/inhibikase-therapeutics-announces-2024-financial-results Thu, 27 Mar 25 16:01:00 -0400 https://www.inhibikase.com/news/press-releases/detail/129/inhibikase-therapeutics-announces-2024-financial-results <![CDATA[Inhibikase Announces Expansion of Senior Leadership Team]]> https://www.inhibikase.com/news/press-releases/detail/128/inhibikase-announces-expansion-of-senior-leadership-team Mon, 24 Feb 25 08:00:00 -0500 https://www.inhibikase.com/news/press-releases/detail/128/inhibikase-announces-expansion-of-senior-leadership-team